Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine
Summary
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Description
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source